| 24314639
|
Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance. |
Virology |
2014 |
Basta HA;Ashraf S;Sgro JY;Bochkov YA;Gern JE;Palmenberg AC |
View
More |
| 24314648
|
Modeling of the human rhinovirus C capsid suggests a novel topography with insights on receptor preference and immunogenicity. |
Virology |
2014 |
Basta HA;Sgro JY;Palmenberg AC |
View
More |
| 24360829
|
Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones. |
Bioorg Med Chem |
2014 |
Conti C;Proietti Monaco L;Desideri N |
View
More |
| 24900468
|
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus. |
ACS Med Chem Lett |
2012 |
Feil SC;Hamilton S;Krippner GY;Lin B;Luttick A;McConnell DB;Nearn R;Parker MW;Ryan J;Stanislawski PC;Tucker SP;Watson KG;Morton CJ |
View
More |
| 24948704
|
A novel benzonitrile analogue inhibits rhinovirus replication. |
J Antimicrob Chemother |
2014 |
Lacroix C;Querol-Audi J;Roche M;Franco D;Froeyen M;Guerra P;Terme T;Vanelle P;Verdaguer N;Neyts J;Leyssen P |
View
More |
| 27049678
|
VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection. |
Eur J Med Chem |
2016 |
Da Costa L;Roche M;Scheers E;Coluccia A;Neyts J;Terme T;Leyssen P;Silvestri R;Vanelle P |
View
More |
| 28242170
|
3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors. |
Bioorg Med Chem |
2017 |
Conti C;Proietti Monaco L;Desideri N |
View
More |
| 28331093
|
Structural Characterization of Human Coronavirus NL63 N Protein. |
J Virol |
2017 |
Szelazek B;Kabala W;Kus K;Zdzalik M;Twarda-Clapa A;Golik P;Burmistrz M;Florek D;Wladyka B;Pyrc K;Dubin G |
View
More |
| 28515298
|
Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Augments mRNA Translation. |
J Virol |
2017 |
Jeeva S;Cheng E;Ganaie SS;Mir MA |
View
More |
| 28528442
|
Herpesvirus Capsid Assembly and DNA Packaging. |
Adv Anat Embryol Cell Biol |
2017 |
Heming JD;Conway JF;Homa FL |
View
More |
| 28987610
|
Heterocyclic pharmacochemistry of new rhinovirus antiviral agents: A combined computational and experimental study. |
Eur J Med Chem |
2017 |
Da Costa L;Scheers E;Coluccia A;Rosetti A;Roche M;Neyts J;Terme T;Cirilli R;Mirabelli C;Silvestri R;Vanelle P |
View
More |
| 31416365
|
Overview of human rhinovirus immunogenic epitopes for rational vaccine design. |
Expert Rev Vaccines |
2019 |
Stepanova E;Isakova-Sivak I;Rudenko L |
View
More |
| 31462495
|
Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site. |
Proc Natl Acad Sci U S A |
2019 |
Wald J;Pasin M;Richter M;Walther C;Mathai N;Kirchmair J;Makarov VA;Goessweiner-Mohr N;Marlovits TC;Zanella I;Real-Hohn A;Verdaguer N;Blaas D;Schmidtke M |
View
More |
| 31482072
|
Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion. |
Front Cell Infect Microbiol |
2019 |
Cifuente JO;Moratorio G |
View
More |
| 31881489
|
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. |
Eur J Med Chem |
2020 |
Egorova A;Kazakova E;Jahn B;Ekins S;Makarov V;Schmidtke M |
View
More |
| 32132268
|
Low intraspecific variation of Frog virus 3 with evidence for novel FV3-like isolates in central and northwestern Canada. |
Dis Aquat Organ |
2019 |
Grant SA;Bienentreu JF;Vilaca ST;Brunetti CR;Lesbarreres D;Murray DL;Kyle CJ |
View
More |
| 32676065
|
nanoDSF: In vitro Label-Free Method to Monitor Picornavirus Uncoating and Test Compounds Affecting Particle Stability. |
Front Microbiol |
2020 |
Real-Hohn A;Groznica M;Loffler N;Blaas D;Kowalski H |
View
More |
| 33582369
|
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay. |
Int J Infect Dis |
2021 |
Echeverria G;Guevara A;Coloma J;Ruiz AM;Vasquez MM;Tejera E;de Waard JH |
View
More |
| 33920339
|
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold. |
Life (Basel) |
2021 |
Swanson J;Fragkoudis R;Hawes PC;Newman J;Burman A;Panjwani A;Stonehouse NJ;Tuthill TJ |
View
More |
| 33961065
|
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19. |
Naunyn Schmiedebergs Arch Pharmacol |
2021 |
Raj K;Kaur K;Gupta GD;Singh S |
View
More |
| 34517053
|
Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species. |
Antiviral Res |
2021 |
Lanko K;Sun L;Froeyen M;Leyssen P;Delang L;Mirabelli C;Neyts J |
View
More |
| 34705560
|
Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating. |
J Virol |
2022 |
Murer L;Petkidis A;Vallet T;Vignuzzi M;Greber UF |
View
More |
| 36374110
|
Molecular Determinants of Human Rhinovirus Infection, Assembly, and Conformational Stability at Capsid Protein Interfaces. |
J Virol |
2022 |
Valiente L;Lopez-Arguello S;Rodriguez-Huete A;Valbuena A;Mateu MG |
View
More |
| 37030533
|
Computer-aided drug design in seeking viral capsid modulators. |
Drug Discov Today |
2023 |
Zhao S;Zhang X;da Silva-Junior EF;Zhan P;Liu X |
View
More |
| 37806749
|
Single-Molecule Analysis of Genome Uncoating from Individual Human Rhinovirus Particles, and Modulation by Antiviral Drugs. |
Small |
2023 |
Valbuena A;Strobl K;Gil-Redondo JC;Valiente L;de Pablo PJ;Mateu MG |
View
More |
